ASTH
Astrana Health, Inc.
NASDAQ · Healthcare · Medical - Care Facilities · US
$34.36
+0.17%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- $0.44
- Revenue estimate
- $1.0B
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- $0.40
- EPS estimate
- $0.34
- Revenue actual
- $972.5M
- Revenue estimate
- $982.2M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +7.3%
- Revenue beats (12Q)
- 4
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $55
- PT range
- $50 – $65
- Analysts
- 5
5 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | $0.34 | $0.40 | Beat 19.12% | $972.5M |
| May 7, 2026 | $0.29 | $0.74 | Beat 155.17% | $965.1M |
| Nov 6, 2025 | $0.47 | $0.01 | Miss -97.87% | $956.0M |
| Aug 7, 2025 | $0.36 | $0.19 | Miss -47.22% | $654.8M |
| May 8, 2025 | $0.23 | $0.14 | Miss -39.13% | $620.4M |
| Feb 27, 2025 | $0.22 | -$0.15 | Miss -168.18% | $665.2M |
| Nov 7, 2024 | $0.32 | $0.33 | Beat 3.13% | $478.7M |
| Feb 27, 2024 | $0.15 | $0.26 | Beat 73.33% | $353.0M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026